Kai Hu
About
Kai Hu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology.
According to data from OpenAlex, Kai Hu has authored 69 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cardiology and Cardiovascular Medicine, 29 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in Kai Hu's work include Cardiovascular Function and Risk Factors (18 papers), Cardiac Imaging and Diagnostics (7 papers) and Cardiac Fibrosis and Remodeling (7 papers). Kai Hu is often cited by papers focused on Cardiovascular Function and Risk Factors (18 papers), Cardiac Imaging and Diagnostics (7 papers) and Cardiac Fibrosis and Remodeling (7 papers). Kai Hu collaborates with scholars based in China, United States and Germany. Kai Hu's co-authors include Björn Olsén, Junbo Ge, Aijun Sun, Zhen Dong, Xiaolei Sun, Georg Ertl, Aijun Sun, Yunzeng Zou, Junbo Ge and Cheng Shen and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.
In The Last Decade
Kai Hu
66 papers receiving 2.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Kai Hu China | 26 | 1.1k | 750 | 311 | 282 | 271 | 69 | 2.3k | ||
| John Fassett United States | 28 | 1.1k 1.0× | 742 1.0× | 456 1.5× | 211 0.7× | 165 0.6× | 46 | 2.2k | ||
| Paul A.J. Krijnen Netherlands | 27 | 801 0.7× | 672 0.9× | 263 0.8× | 313 1.1× | 297 1.1× | 96 | 2.4k | ||
| Mutsuo Harada Japan | 18 | 1.2k 1.1× | 954 1.3× | 311 1.0× | 158 0.6× | 209 0.8× | 34 | 2.3k | ||
| Fei Han China | 30 | 1.1k 1.0× | 428 0.6× | 237 0.8× | 201 0.7× | 251 0.9× | 177 | 3.0k | ||
| Hideshi Okada Japan | 27 | 943 0.9× | 1.1k 1.5× | 188 0.6× | 466 1.7× | 192 0.7× | 120 | 2.7k | ||
| Christen P. Dahl Norway | 28 | 1.2k 1.1× | 946 1.3× | 190 0.6× | 192 0.7× | 140 0.5× | 54 | 2.4k | ||
| Leif Erik Vinge Norway | 27 | 1.5k 1.4× | 1.1k 1.4× | 180 0.6× | 202 0.7× | 220 0.8× | 46 | 2.5k | ||
| Masashi Arai Japan | 33 | 1.5k 1.3× | 1.2k 1.6× | 235 0.8× | 227 0.8× | 175 0.6× | 76 | 2.9k | ||
| Aijun Sun China | 34 | 1.6k 1.5× | 1.1k 1.4× | 279 0.9× | 419 1.5× | 443 1.6× | 115 | 3.4k | ||
| Detlef Wencker United States | 14 | 1.1k 1.0× | 1.0k 1.4× | 156 0.5× | 235 0.8× | 344 1.3× | 27 | 2.4k |
Countries citing papers authored by Kai Hu
Since
Specialization
Citations
This map shows the geographic impact of Kai Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Hu more than expected).
Fields of papers citing papers by Kai Hu
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kai Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Hu. The network helps show where Kai Hu may publish in the future.
Co-authorship network of co-authors of Kai Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Kai Hu. A scholar is included among the top collaborators of Kai Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Hu. Kai Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Deng, Ying, Kai Hu, Yuying Sun, et al.. (2025). DNA network-enhanced electrochemical cytosensor for analyzing mesenchymal CTCs and epithelial-mesenchymal transition in ovarian cancer. Chemical Engineering Journal. 512. 162728–162728.
2.
Gao, Rifeng, Kun Yang, Xiaolei Sun, et al.. (2024). Aldehyde dehydrogenase 2 serves as a key cardiometabolic adaptation regulator in response to plateau hypoxia in mice. Translational research. 267. 25–38.
3.
Wang, Qi, Bin Li, Fei Yu, et al.. (2024). Impact of Panvascular Disease on Exercise Capacity and Clinical Outcomes in Patients with Heart Failure with Reduced Ejection Fraction. CJC Open. 6(12). 1434–1442.
4.
Zhang, Xue, Kun Chen, Shuang Zhao, et al.. (2023). Immune response gene 1 deficiency aggravates high fat diet-induced nonalcoholic fatty liver disease via promotion of redox-sensitive AKT suppression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(4). 166656–166656.
5.
Yang, Kun, Yongchao Zhao, Jingjing Hu, et al.. (2023). ALKBH5 induces fibroblast-to-myofibroblast transformation during hypoxia to protect against cardiac rupture after myocardial infarction. Journal of Advanced Research. 61. 193–209.
6.
Dong, Zhen, Bowen Liu, Lihong Pan, et al.. (2022). Effects of the ketogenic diet in mice with hind limb ischemia. Nutrition & Metabolism. 19(1). 59–59.
7.
Zhou, Jingmin, Xuejuan Jin, Jun Zhou, et al.. (2020). Digoxin is Associated with Worse Outcomes in Patients with Heart Failure with Reduced Ejection Fraction. ESC Heart Failure. 7(1). 139–147.
8.
Jiang, Hao, Daile Jia, Beijian Zhang, et al.. (2020). Exercise improves cardiac function and glucose metabolism in mice with experimental myocardial infarction through inhibiting HDAC4 and upregulating GLUT1 expression. Basic Research in Cardiology. 115(3). 28–28.
9.
Yuan, Xianwen, Yuanyuan Sun, Qi Cheng, et al.. (2020). Proteomic analysis to identify differentially expressed proteins between subjects with metabolic healthy obesity and non-alcoholic fatty liver disease. Journal of Proteomics. 221. 103683–103683.
10.
Wang, Yanyan, Yuyuan Fan, Yu Song, et al.. (2019). Angiotensin II induces apoptosis of cardiac microvascular endothelial cells via regulating PTP1B/PI3K/Akt pathway. In Vitro Cellular & Developmental Biology - Animal. 55(10). 801–811.
11.
Ma, Jiaqi, Zhangwei Chen, Yuanji Ma, et al.. (2019). MicroRNA‐19a attenuates hypoxia‐induced cardiomyocyte apoptosis by downregulating NHE‐1 expression and decreasing calcium overload. Journal of Cellular Biochemistry. 121(2). 1747–1758.
12.
Hu, Kai & Björn Olsén. (2016). Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. Journal of Clinical Investigation. 126(2). 509–526.
13.
Cui, Xiaotong, Jingmin Zhou, Xuejuan Jin, et al.. (2016). Prevalence and correlates of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in elderly community residents. International Journal of Cardiology. 227. 820–825.
14.
Sun, Aijun, Yong Cheng, Yingmei Zhang, et al.. (2014). Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy. Journal of Molecular and Cellular Cardiology. 71. 92–104.
15.
Zhou, Jingmin, Xiaotong Cui, Xuejuan Jin, et al.. (2014). Association of Renal Biochemical Parameters with Left Ventricular Diastolic Dysfunction in a Community-Based Elderly Population in China: A Cross-Sectional Study. PLoS ONE. 9(2). e88638–e88638.
16.
Shen, Cheng, Cong Wang, Fan Fan, et al.. (2014). Acetaldehyde dehydrogenase 2 (ALDH2) deficiency exacerbates pressure overload-induced cardiac dysfunction by inhibiting Beclin-1 dependent autophagy pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(2). 310–318.
17.
Fan, Fan, Cong Wang, Xin Ma, et al.. (2014). Impact of chronic low to moderate alcohol consumption on blood lipid and heart energy profile in acetaldehyde dehydrogenase 2-deficient mice. Acta Pharmacologica Sinica. 35(8). 1015–1022.
18.
Zhao, Jingjing, Hong Zhu, Shijun Wang, et al.. (2013). Naoxintong Protects against Atherosclerosis through Lipid-lowering and Inhibiting Maturation of Dendritic Cells in LDL Receptor Knockout Mice fed a High-fat Diet. Current Pharmaceutical Design. 19(33). 5891–5896.
19.
Sun, Aijun, Zhaohui Qiu, Gang Zhao, et al.. (2012). The therapeutic effect of Rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end‐stage hypertension in rats. Journal of Cellular and Molecular Medicine. 16(9). 2227–2237.
20.
Nahrendorf, Matthias, Frank Wiesmann, Karl‐Heinz Hiller, et al.. (2000). In Vivo Assessment of Cardiac Remodeling After Myocardial Infarction in Rats by Cine-Magnetic Resonance Imaging. Journal of Cardiovascular Magnetic Resonance. 2(3). 171–180.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by John Fassett Breakdown of academic impact, for papers by Paul A.J. Krijnen Breakdown of academic impact, for papers by Mutsuo Harada Breakdown of academic impact, for papers by Fei Han Breakdown of academic impact, for papers by Hideshi Okada Breakdown of academic impact, for papers by Christen P. Dahl Breakdown of academic impact, for papers by Leif Erik Vinge Breakdown of academic impact, for papers by Masashi Arai Breakdown of academic impact, for papers by Aijun Sun Breakdown of academic impact, for papers by Detlef Wencker